Skip to main content
FLGT
NASDAQ Industrial Applications And Services

Fulgent 10-Q: Q3 Revenue $90.4M, Gross Margin 35%, Nine-Month Loss $67.5M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$18.66
Mkt Cap
$513.435M
52W Low
$13.46
52W High
$31.04
52W Position info
39% above low
Off High info
40% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

FLGT sits 39% above its 52-week low of $13.46.

Summary

Fulgent's Q3 10-Q confirms revenue of $90.4 million with gross margin down to 35% and a nine-month loss of $67.5 million, while flagging a thin 11% cushion on its lab-services goodwill and unresolved DOJ/HRSA billing investigations.


Key Events · Earnings and Guidance · FLGT

  • Q3 Revenue Up 8%, Margins Compress

    Revenue rose to $90.4 million from $84.1 million, but gross margin fell to 35% from 42% and gross profit dropped to $31.9 million from $35.5 million.

  • Nine-Month Loss Reaches $67.5M

    For the nine months, GAAP net loss attributable to Fulgent was $67.5 million, or $(2.34) per share, versus $37.1 million, or $(1.21), a year earlier.

  • Cash Flow Flattered by Tax Refund

    Operating cash flow of $92.6 million included a $112.3 million federal tax refund; excluding it, operations used roughly $19.8 million of cash in the nine months.

  • Lab Goodwill Cushion Only 11%

    The laboratory services reporting unit's $1,045.0 million fair value exceeded its $943.5 million carrying value by about 11%, which the company calls heightened risk of future impairment.


Analysis · FLGT · Industrial Applications And Services

The 10-Q confirms the weak quarter already flagged in the 8-K, but the balance-sheet and cash detail is what matters more. Gross margin fell to 35% from 42% as billing-system transition backlogs and a shrinking largest customer squeezed collections, and the nine-month GAAP loss reached $67.5 million. Cash flow looks strong only because of a $112.3 million federal tax refund; excluding it, operations burned about $19.8 million. Liquidity of $652.4 million buys time, but the laboratory services unit's fair value now exceeds its carrying value by just 11%, leaving goodwill at real risk if margins don't recover.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FLGT was trading at $18.66 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $513.4M. The 52-week trading range was $13.46 to $31.04. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FLGT - Latest Insights

FLGT
Nov 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.66
Real-time Price: $23.78 info
Change: +$5.11 (+27%) info
Market Cap: $692.328M info
FLGT
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $18.66
Real-time Price: $23.78 info
Change: +$5.11 (+27%) info
Market Cap: $692.328M info
FLGT
Jul 30, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.80
Real-time Price: $23.78 info
Change: +$9.97 (+72%) info
Market Cap: $692.328M info
FLGT
Jul 30, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.80
Real-time Price: $23.78 info
Change: +$9.97 (+72%) info
Market Cap: $692.328M info
FLGT
Jun 01, 2026, 7:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $18.09
Real-time Price: $23.78 info
Change: +$5.68 (+31%) info
Market Cap: $692.328M info